Prednisone is NOT Recommended for Post-Herpetic Neuralgia
A prednisone taper should not be used to treat this patient's post-herpetic neuralgia (PHN). Corticosteroids have been definitively shown to be ineffective in preventing or treating PHN, and this patient needs alternative management for her established neuropathic pain 1, 2.
Why Corticosteroids Don't Work for PHN
The evidence is clear and consistent: corticosteroids do not prevent postherpetic neuralgia 1. A Cochrane meta-analysis of 787 patients demonstrated that oral corticosteroids given during acute herpes zoster showed no benefit in preventing PHN at 6 months (RR 0.95; 95% CI 0.45-1.99) 1. While corticosteroids may provide modest relief during the acute phase of shingles, they have no role once PHN is established 2. Your patient is now in the chronic pain phase—the lesions have healed and she has persistent neuropathic pain—making steroids both ineffective and potentially harmful given her age.
What You Should Do Instead
Immediate Action: Optimize Gabapentin or Switch Agents
First-line therapy for PHN includes gabapentinoids, tricyclic antidepressants, and topical agents 3. Since she's already on gabapentin but experiencing problematic side effects (lightheadedness affecting her safety-sensitive job), you have two options:
Switch to pregabalin: This may be better tolerated with easier titration. Start at 25-50 mg/day (lower dose given her age) and titrate slowly 3. Pregabalin has more predictable pharmacokinetics and may cause less dizziness at therapeutic doses.
Add or switch to a tricyclic antidepressant: Nortriptyline is preferred in older adults over amitriptyline due to fewer anticholinergic effects. Start at 10-25 mg at bedtime 4.
Consider Topical Therapy
Topical agents are particularly appropriate for older adults due to minimal systemic absorption and high safety profile 3. Options include:
- Lidocaine 5% patches: Moderate evidence for PHN, applied directly to painful area 3
- High-concentration capsaicin (8%): Moderate evidence specifically for PHN 3
These can be used alone or in combination with systemic agents, and won't impair her ability to drive.
Combination Therapy if Monotherapy Fails
If single agents provide inadequate relief, combination therapy with gabapentin/pregabalin plus a tricyclic antidepressant has shown superior efficacy to either alone 4. The combination allows lower doses of each medication, potentially reducing side effects while improving pain control.
Critical Safety Considerations
Her occupation as a bus driver is paramount: Any medication causing lightheadedness or impaired cognition is unacceptable. This makes topical agents particularly attractive as first-line alternatives.
Age-related concerns: At 68, she likely has some degree of renal impairment. Gabapentin dosing should be adjusted based on creatinine clearance 5. If CrCl is 30-59 mL/min, maximum dose should be 1400 mg/day in divided doses 5.
Corticosteroid risks in older adults: Beyond being ineffective for PHN, a prednisone taper carries risks of hyperglycemia, hypertension, osteoporosis, and infection—particularly problematic in a 68-year-old 3.
Practical Algorithm
- Stop or reduce gabapentin if side effects are intolerable
- Start topical lidocaine 5% patches immediately (safest for her driving)
- Add low-dose nortriptyline 10-25 mg at bedtime OR switch to pregabalin 25-50 mg/day with slow titration
- If inadequate response in 2-3 weeks, consider combination therapy
- Reserve interventional procedures (nerve blocks, radiofrequency) for refractory cases 6
The bottom line: Prednisone has no role in treating established PHN and would expose your patient to unnecessary risks without benefit. Focus on evidence-based neuropathic pain management with agents that won't compromise her occupational safety.